Amanote Research
Register
Sign In
CTLA-4 Based Therapy (MDX-010)
Breast Cancer Research
- United Kingdom
doi 10.1186/bcr731
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
October 1, 2003
Authors
A Korman
Publisher
Springer Science and Business Media LLC
Related search
Ctla-4 (Cd152)
Science-Business eXchange
Cytotoxic T-Lymphocyte Antigen 4 (Ctla-4) Gene Polymorphisms in Bronchial Asthma.
International Journal of Advanced Research
Ipilimumab: An Anti-Ctla-4 Antibody for Metastatic Melanoma
Clinical Cancer Research
Cancer Research
Oncology
PD-1- And CTLA-4-Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses
Science Translational Medicine
Medicine
CTLA-4 Blockade During Dendritic Cell Based Booster Vaccination Influences Dendritic Cell Survival and CTL Expansion
Journal of Immune Based Therapies and Vaccines
CTLA-4 Blockade Synergizes With Cryoablation to Mediate Tumor Rejection
OncoImmunology
Oncology
Allergy
Immunology
Radiotherapy Enhances Responses of Lung Cancer to CTLA-4 Blockade
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Dose-Dependent Effect of Anti-Ctla-4 on Survival in Sepsis
Shock
Critical Care
Emergency Medicine
Intensive Care Medicine
CTLA-4 Gene Polymorphisms Are Associated With Obesity in Turner Syndrome
Genetics and Molecular Biology
Genetics
Molecular Biology